NasdaqGS - Delayed Quote USD
Shattuck Labs, Inc. (STTK)
1.0100
-0.0700
(-6.48%)
At close: May 30 at 4:00:01 PM EDT
1.0100
0.00
(0.00%)
After hours: May 30 at 6:40:22 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 5 |
| Avg. Estimate | -0.25 | -0.25 | -0.96 | -0.89 |
| Low Estimate | -0.29 | -0.32 | -1.04 | -1.22 |
| High Estimate | -0.21 | -0.21 | -0.87 | -0.57 |
| Year Ago EPS | -0.42 | -0.33 | -1.49 | -0.96 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | 1.61M | 3M | 5.72M | -- |
| Sales Growth (year/est) | -100.00% | -100.00% | -100.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.41 | -0.42 | -0.32 | -0.28 |
| EPS Actual | -0.42 | -0.33 | -0.37 | -0.27 |
| Difference | -0.01 | 0.09 | -0.05 | 0.01 |
| Surprise % | -1.58% | 20.78% | -16.07% | 4.42% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.25 | -0.25 | -0.96 | -0.89 |
| 7 Days Ago | -0.27 | -0.28 | -1.09 | -0.99 |
| 30 Days Ago | -0.27 | -0.28 | -1.09 | -1 |
| 60 Days Ago | -0.2 | -0.2 | -0.94 | -0.97 |
| 90 Days Ago | -0.2 | -0.2 | -0.94 | -0.97 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 2 |
| Up Last 30 Days | -- | -- | -- | 3 |
| Down Last 7 Days | 1 | 2 | 1 | -- |
| Down Last 30 Days | 1 | 2 | 2 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| STTK | 41.67% | 25.00% | 35.74% | 7.38% |
| S&P 500 | 13.08% | 2.49% | 7.56% | 13.96% |
Upgrades & Downgrades
| Reiterates | Needham: Hold to Hold | 3/27/2025 |
| Reiterates | HC Wainwright & Co.: Neutral to Neutral | 3/27/2025 |
| Initiated | Leerink Partners: Outperform | 3/17/2025 |
| Reiterates | HC Wainwright & Co.: Neutral | 11/15/2024 |
| Reiterates | Needham: Hold | 11/14/2024 |
| Downgrade | Citigroup: Buy to Neutral | 10/2/2024 |
Related Tickers
FHTX Foghorn Therapeutics Inc.
4.0800
-5.56%
PRLD Prelude Therapeutics Incorporated
0.8859
-1.77%
CCCC C4 Therapeutics, Inc.
1.2500
-5.30%
SPRB Spruce Biosciences, Inc.
0.0654
-5.90%
NRIX Nurix Therapeutics, Inc.
10.63
-0.09%
CGEM Cullinan Therapeutics, Inc.
8.65
-0.40%
KYMR Kymera Therapeutics, Inc.
29.64
-2.02%
DSGN Design Therapeutics, Inc.
3.7300
-6.98%
GBIO Generation Bio Co.
0.3782
-2.58%
IPHA Innate Pharma S.A.
2.1900
0.00%